An update from Merit Medical Systems ( ($MMSI) ) is now available. On January 28, 2025, Merit Medical Systems held a conference call to discuss ...
A new study suggests clinical utility of the first FDA-approved genetic test to help gauge an individual’s risk for opioid ...
Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...
De Novo is an approach for the FDA to classify novel medical devices based on risk for devices whose safety and effectiveness can be ensured through general controls or specific controls (i.e., low ...
Irish neurotech company CergenX has received the Breakthrough Device Designation from the US FDA while being accepted into ...
Koh Young Technology gains FDA approval for medical robot in brain surgery Koh Young Technology secures FDA clearance for innovative robotic system in neurosurgery ...
CergenX announced today that the FDA granted breakthrough device designation for its Wave device for neonatal brain ...
A CergenX-led consortium, including UCC/ INFANT, was awarded €6.7 million in funding from The Disruptive Technologies ...
Many AI-enabled medtech products leverage machine learning or deep learning. In order to address the opaque decision-making ...